Fischer Medical Ventures Profit & Loss Annual

BSE: 524743 | NSE: FISCHER | ISIN: INE771F01041 | Sector: Chemical Manufacturing

32.60 -0.49 (-1.48%)Updated : 07 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	257.43	107.69	19.30	0.16
Other Net	-0.70	0.16	0.50	0.00
Total Adjustmentsto Net Income	0.00	0.00	-	-
Diluted Weighted Average Shares	69.25	63.80	11.14	0.17
Gain( Loss)on Saleof Assets	-5.52	-1.30	-	-
Depreciation/ Amortization	2.98	1.62	0.18	-
Operating Income	51.15	3.01	1.68	0.02
Net Income	32.21	1.21	1.84	-0.04
Income Availableto Com Excl Extra Ord	32.21	1.21	1.84	-0.04
Other Operating Expenses Total	39.24	9.26	2.29	0.12
Net Income Before Taxes	46.36	2.22	2.11	0.00
Minority Interest	1.19	-	-	-
Net Income After Taxes	31.02	1.21	1.84	-0.04
Income Availableto Com Incl Extra Ord	32.21	1.21	1.84	-0.04
Costof Revenue Total	195.59	91.59	16.45	-
Gross Profit	112.99	19.11	4.53	-
Interest Inc( Exp) Net- Non- Op Total	1.43	0.35	-0.07	-0.02
Unusual Expense( Income)	-2.29	-	-	-
Diluted Net Income	32.21	1.21	1.84	-0.04
DPS- Common Stock Primary Issue	0.05	0.05	-	-
Provisionfor Income Taxes	15.34	1.01	0.27	0.04
period Type	-	-	-	-
Net Income Before Extra Items	32.21	1.21	1.84	-0.04
Total Revenue	308.58	110.70	20.98	0.18
period Length	12.00	12.00	12.00	12.00
Revenue	308.58	110.70	20.98	0.18
Selling/ General/ Admin Expenses Total	21.91	5.23	0.38	0.05
Diluted Normalized EPS	0.50	0.03	0.17	-0.21
Diluted EPS Excluding Extra Ord Items	0.47	0.02	0.17	-0.21